In Vitro Activities of Garenoxacin (BMS-284756) against Haemophilus influenzae Isolates with Different Fluoroquinolone Susceptibilities

The in vitro activity of garenoxacin (BMS-284756) against 62 clinical Haemophilus influenzae isolates with different fluoroquinolone susceptibilities was determined by the microdilution susceptibility testing method and compared with the activities of other oral quinolones and nonquinolone oral anti...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Pérez-Vázquez, María, Román, Federico, Aracil, Belen, Cantón, Rafael, Campos, José
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 2003
Schlagworte:	Susceptibility
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC253788/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14576114/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.11.3539-3541.2003
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!